Sacred journeys and pilgrimages: health risks associated with travels for religious purposes.

Pilgrimage communicable diseases health risks mass gatherings non-communicable diseases religious travels

Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
31 Aug 2024
Historique:
received: 08 07 2024
revised: 25 08 2024
accepted: 29 08 2024
medline: 1 9 2024
pubmed: 1 9 2024
entrez: 31 8 2024
Statut: aheadofprint

Résumé

Pilgrimages and travel to religious Mass Gatherings (MGs) are part of all major religions. This narrative review aims to describe some characteristics, including health risks, of the more well known and frequently undertaken ones. A literature search was conducted using keywords related to the characteristics (frequency of occurrence, duration, calendar period, reasons behind their undertaking and the common health risks) of Christian, Muslim, Hindu, Buddhist and Jewish religious MGs. About 600 million trips are undertaken to religious sites annually. The characteristics varies between religions and between pilgrimages. However, religious MGs share common health risks, but these are reported in a heterogenous manner. European Christian pilgrimages reported both communicable diseases, such as norovirus outbreaks linked to the Marian Shrine of Lourdes in France, and noncommunicable diseases (NCD). NCD predominated at the Catholic pilgrimage to the Basilica of Our Lady of Guadalupe in Mexico, which documented 11 million attendees in one week. The Zion Christian Church Easter gathering in South Africa, attended by about 10 million pilgrims, reported mostly motor vehicles accidents. Muslim pilgrimages, such as the Arbaeen (20 million pilgrims) and Hajj documented a high incidence of respiratory tract infections, up to 80% during Hajj. Heat injuries and stampedes have been associated with Hajj. The Hindu Kumbh Mela pilgrimage, which attracted 100 million pilgrims in 2013, documented respiratory conditions in 70% of consultations. A deadly stampede occurred at the 2021 Jewish Lag BaOmer MG. Communicable and NCD differ among the different religious MGs. Gaps exists in the surveillance, reporting, and data accessibility of health risks associated with religious MGs. A need exists for the uniform implementation of a system of real-time monitoring of diseases and morbidity patterns, utilising standardised modern information-sharing platforms. The health needs of pilgrims can then be prioritised by developing specific and appropriate guidelines.

Sections du résumé

BACKGROUND BACKGROUND
Pilgrimages and travel to religious Mass Gatherings (MGs) are part of all major religions. This narrative review aims to describe some characteristics, including health risks, of the more well known and frequently undertaken ones.
METHODS METHODS
A literature search was conducted using keywords related to the characteristics (frequency of occurrence, duration, calendar period, reasons behind their undertaking and the common health risks) of Christian, Muslim, Hindu, Buddhist and Jewish religious MGs.
RESULTS RESULTS
About 600 million trips are undertaken to religious sites annually. The characteristics varies between religions and between pilgrimages. However, religious MGs share common health risks, but these are reported in a heterogenous manner. European Christian pilgrimages reported both communicable diseases, such as norovirus outbreaks linked to the Marian Shrine of Lourdes in France, and noncommunicable diseases (NCD). NCD predominated at the Catholic pilgrimage to the Basilica of Our Lady of Guadalupe in Mexico, which documented 11 million attendees in one week. The Zion Christian Church Easter gathering in South Africa, attended by about 10 million pilgrims, reported mostly motor vehicles accidents. Muslim pilgrimages, such as the Arbaeen (20 million pilgrims) and Hajj documented a high incidence of respiratory tract infections, up to 80% during Hajj. Heat injuries and stampedes have been associated with Hajj. The Hindu Kumbh Mela pilgrimage, which attracted 100 million pilgrims in 2013, documented respiratory conditions in 70% of consultations. A deadly stampede occurred at the 2021 Jewish Lag BaOmer MG.
CONCLUSION CONCLUSIONS
Communicable and NCD differ among the different religious MGs. Gaps exists in the surveillance, reporting, and data accessibility of health risks associated with religious MGs. A need exists for the uniform implementation of a system of real-time monitoring of diseases and morbidity patterns, utilising standardised modern information-sharing platforms. The health needs of pilgrims can then be prioritised by developing specific and appropriate guidelines.

Identifiants

pubmed: 39216102
pii: 7746738
doi: 10.1093/jtm/taae122
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of International Society of Travel Medicine.

Auteurs

Salim Parker (S)

Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Robert Steffen (R)

Epidemiology, Biostatistics and Prevention Institute, Department of Public and Global Health, Division of Infectious Diseases, World Health Organization Collaborating Centre for Travelers' Health, University of Zurich, Zurich, Switzerland.
Division of Epidemiology, Human Genetics & Environmental Sciences, University of Texas School of Public Health, Houston, TX, USA.

Harunor Rashid (H)

The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, and Sydney Infectious Diseases Institute, The University of Sydney, Westmead, New South Wales, Australia.

Miguel M Cabada (MM)

Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Cusco Branch-Alexander von Humboldt Tropical Medicine Institute, Universidad Peruana Cayetano Heredia, Lima, Peru.

Ziad A Memish (ZA)

King Salman Humanitarian Aid & Relief Center, Riyadh, Kingdom of Saudi Arabia.
Hubert Department of Global Health, Rollins School of Public Health, Emory, University, Atlanta, USA.

Philippe Gautret (P)

IHU-Méditerranée Infection, Marseille, France.
Aix Marseille Univ, AP-HM, SSA, RITMES, Marseille, France.

Cheikh Sokhna (C)

IHU-Méditerranée Infection, Marseille, France.
Aix Marseille Univ, AP-HM, SSA, RITMES, Marseille, France.
Aix Marseille Univ, IRD, AP-HM, SSA, MINES, Marseille, France.

Avinash Sharma (A)

BRIC-National Centre for Cell Science, Pune, 411007, India.
School of Agriculture, Graphic Era Hill University, Dehradun, 248002, India.

David R Shlim (DR)

Jackson Hole Travel and Tropical Medicine, Jackson Hole, Wyoming, USA.

Eyal Leshem (E)

Sheba Medical Center, Ramat Gan and School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dominic E Dwyer (DE)

New South Wales Health Pathology-ICPMR, Westmead Hospital and University of Sydney, Westmead, New South Wales, Australia.

Faris Lami (F)

Baghdad College of Medicine, Baghdad, Iraq.

Santanu Chatterjee (S)

KPC Medical College and Hospitals, Kolkata, India.

Shuja Shafi (S)

Mass Gatherings and Global Health Network, London, UK.

Alimuddin Zumla (A)

Department of Infection, Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London, UK.
NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.

Ozayr Mahomed (O)

Discipline of Public Health Medicine, University of KwaZulu Natal, Durban, South Africa.

Classifications MeSH